Julia Kristensson (Rolf)

Julia (Rolf) Kristensson is a Principal Scientist at Bicycle Therapeutics since November 2016, specializing in assay biology within the therapeutics team. Prior experience includes working as a Biologist at Astex Pharmaceuticals from November 2014 to November 2016, focusing on target validation in oncology. Julia's research background features post-doctoral roles at The University of Dundee, where research concentrated on metabolism in lymphocytes, and The Babraham Institute, which explored PI3K signaling in the immune system. Julia completed a PhD in Immunology at the University of Gothenburg, following a Master’s Degree in Biomedicine from Lund University.